CA Stock MarketDetailed Quotes
PREV PreveCeutical Medical Inc
- 0.025
- +0.005+25.00%
15min DelayMarket Closed Jul 26 13:04 ET
13.50MMarket Cap-25000P/E (TTM)
0.025High0.020Low239.00KVolume0.020Open0.020Pre Close4.98KTurnover0.03052wk High0.05%Turnover Ratio539.90MShares0.01552wk Low-0.001EPS TTM11.75MFloat Cap0.200Historical HighLossP/E (Static)469.90MShs Float0.010Historical Low-0.002EPS LYR25.00%Amplitude--Dividend TTM-2.27P/B1Lot Size--Div YieldTTM
PreveCeutical Medical Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 38.80%-58.42K | -33.39%-296.97K | -116.29%-37.18K | 60.72%-95.46K | 47.78%-222.64K | 228.21K | -120.10%-46.61K | 76.14%-161.25K | -1,469.12%-243.01K | -760.10%-426.39K |
| Net income from continuing operations | 38.25%-235.4K | 13.97%-1.27M | -226.71%-423.07K | 36.58%-381.19K | 14.20%-1.48M | --333.89K | -37,161.94%-797.57K | 45.44%-416.62K | -21.21%-601.06K | 54.58%-1.73M |
| Operating gains losses | ---- | ---- | ---- | ---- | 96.09%-789 | --0 | --0 | --0 | 96.56%-789 | -120.97%-20.19K |
| Depreciation and amortization | 0.40%2.5K | -0.35%9.86K | -62.73%2.45K | 121.05%2.49K | 94.28%9.89K | --6.57K | -20.15%1.09K | -26.28%1.11K | -26.41%1.13K | -93.23%5.09K |
| Asset impairment expenditure | ---- | --0 | ---- | ---- | --38.82K | ---- | ---- | ---- | ---- | --0 |
| Remuneration paid in stock | --0 | -60.66%131.45K | 727.21%42.3K | 512.97%77.36K | 270.96%334.11K | ---6.74K | 2,562.01%308.23K | -3.40%19.99K | -57.67%12.62K | -92.29%90.07K |
| Deferred tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -232.96%-20.48K |
| Other non cashItems | 7.16%79.06K | -19.07%308.99K | 127.95%79.34K | -73.98%73.78K | -41.52%381.81K | ---283.9K | 268.52%297.71K | 8.16%84.42K | -13.07%283.58K | -64.40%652.85K |
| Change In working capital | -27.76%95.42K | 6.53%527.21K | 87.57%261.81K | 114.70%132.09K | -16.52%494.89K | --139.58K | 6.44%143.94K | 1,301.97%149.85K | -65.64%61.53K | -15.10%592.85K |
| -Change in receivables | -101.69%-232 | 657.16%13.11K | -172.30%-2.3K | 1,788.02%13.71K | -106.59%-2.35K | --3.18K | 93.23%-493 | -118.32%-5.76K | -92.10%726 | 486.99%35.72K |
| -Change in prepaid assets | -178.26%-6.37K | 31.48%-18.47K | 249.47%32.55K | 226.02%8.14K | -370.15%-26.96K | ---21.77K | -238.07%-13.9K | 170.53%15.17K | -143.79%-6.46K | -95.13%9.98K |
| -Change in payables and accrued expense | -7.47%102.02K | 1.60%532.57K | 46.39%231.56K | 63.93%110.25K | -4.19%524.2K | --158.17K | 19.54%158.33K | 726.43%140.44K | -56.64%67.26K | 12.31%547.14K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 38.80%-58.42K | -33.39%-296.97K | -116.29%-37.18K | 60.72%-95.46K | 47.78%-222.64K | --228.21K | -120.10%-46.61K | 76.14%-161.25K | -1,469.12%-243.01K | -760.10%-426.39K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 76.26%-779 | 0 | 0 | -486.12%-3.28K | 101.61%850 | 0 | 0 | 0 | 850 | -1,887.89%-52.7K |
| Net PPE purchase and sale | ---779 | --0 | --0 | --0 | -66.00%850 | --0 | --0 | --0 | --850 | --2.5K |
| Net intangibles purchas and sale | --0 | ---- | ---- | ---3.28K | ---- | ---- | ---- | ---- | ---- | -1,982.20%-55.2K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 76.26%-779 | --0 | --0 | -486.12%-3.28K | 101.61%850 | --0 | --0 | --0 | --850 | -1,887.89%-52.7K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -39.47%60.44K | 38.69%293.62K | -61.28%37.2K | 36.08%99.85K | 54.82%211.72K | 96.06K | 180.62%42.09K | -94.85%193 | -36.20%73.38K | -25.87%136.75K |
| Net issuance payments of debt | -39.47%60.44K | 34.56%293.62K | -61.28%37.2K | 164.10%99.85K | 59.57%218.21K | --96.06K | 180.62%42.09K | 1,026.67%42.25K | -67.12%37.81K | -24.85%136.75K |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---42.06K | --35.57K | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---6.49K | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -39.47%60.44K | 38.69%293.62K | -61.28%37.2K | 36.08%99.85K | 54.82%211.72K | --96.06K | 180.62%42.09K | -94.85%193 | -36.20%73.38K | -25.87%136.75K |
| Net cash flow | ||||||||||
| Beginning cash position | -74.54%1.43K | -64.99%5.62K | -31.11%1.68K | -64.99%5.62K | -89.73%16.06K | --2.44K | 102.62%2.64K | -96.73%3.31K | -89.73%16.06K | 449.30%156.44K |
| Current changes in cash | 12.27%1.24K | 66.76%-3.35K | -99.99%18 | 100.66%1.11K | 97.06%-10.08K | --324.27K | -101.83%-4.51K | 76.14%-161.05K | -227.14%-168.78K | -238.93%-342.34K |
| Effect of exchange rate changes | 120.67%135 | -131.96%-842 | 99.92%-269 | -100.42%-653 | -100.18%-363 | ---321.09K | 179.84%4.32K | -66.09%160.38K | 183.11%156.03K | 270.51%201.96K |
| End cash Position | -53.76%2.81K | -74.54%1.43K | -74.54%1.43K | 83.49%6.08K | -64.99%5.62K | --5.62K | -98.27%2.44K | 102.62%2.64K | -96.73%3.31K | -89.73%16.06K |
| Free cash from | 40.05%-59.2K | -33.39%-296.97K | -116.29%-37.18K | 59.37%-98.74K | 53.77%-222.64K | --228.21K | -120.10%-46.61K | 76.24%-161.25K | -1,469.12%-243.01K | -877.46%-481.59K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg